☆ 4.7 Article

Long-term Safety and Efficacy of Efgartigimod in Patients With Generalized Myasthenia Gravis: Interim Results of the ADAPT+ Study

NEUROLOGY (2023)

Get Full Text
Add to Collection

Journal

NEUROLOGY
Volume 99, Issue 23 Supplement 2, Pages S37-S38

Publisher

Ovid Technologies (Wolters Kluwer Health)
DOI: 10.1212/01.wnl.0000903308.81107.e2

Keywords

-

Categories

Clinical Neurology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.